Location History:
- Schallstadt, DE (1991)
- Weimar, DE (1991 - 1992)
Company Filing History:
Years Active: 1991-1992
Title: Hartmut Lobermann: Innovator in Pharmaceutical Development
Introduction
Hartmut Lobermann is a notable inventor based in Weimar, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of tissue proteins and insulin derivatives. With a total of 4 patents to his name, Lobermann's work has had a considerable impact on medical therapies.
Latest Patents
Lobermann's latest patents include innovative formulations and processes. One of his key inventions is a pharmaceutical containing tissue protein PP4, which is designed for the therapy or prophylaxis of disturbances of hemostasis. This patent describes a process for the purification of PP4 using a hydrophobic adsorbent that is insoluble in water. Additionally, he has developed a method for the pasteurization of a solution containing PP4 in the presence of calcium ions and at least one mono- or oligosaccharide or sugar alcohol, and potentially an amino acid. Another significant patent involves insulin derivatives, detailing their preparation and use.
Career Highlights
Lobermann has been associated with Behringwerke Aktiengesellschaft, a company known for its advancements in biopharmaceuticals. His work at this institution has allowed him to focus on innovative solutions that address critical health issues.
Collaborations
Throughout his career, Lobermann has collaborated with esteemed colleagues, including Christiane Bornmann and Eric P Paques. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.
Conclusion
Hartmut Lobermann's contributions to the pharmaceutical industry exemplify the importance of innovation in medical science. His patents reflect a commitment to improving health outcomes through advanced research and development.